Pituitary Adenoma on 18F-Fluciclovine PET/CT

被引:7
|
作者
Wang, Jiaqiong [1 ]
Foley, Mark [1 ]
Kuker, Russ [1 ]
机构
[1] Jackson Mem Hosp, Miller Sch Med, Dept Radiol, Univ Miami Hosp,Div Nucl Med, Miami, FL 33136 USA
关键词
pituitary adenoma; prostate cancer; MRI; F-18-Fluciclovine PET/CT; ACID; RADIOTRACER;
D O I
10.1097/RLU.0000000000002777
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 69-year-old man presented with lower urinary tract symptoms and prostate biopsy showed prostate cancer. F-18-Fluciclovine PET/CT revealed abnormal increased radiotracer uptake within the prostate gland, and multiple osseous structures, suspicious for tumoral involvement. Incidentally, an expansile soft tissue density mass arising from sella turcica demonstrated increased radiotracer activity. MRI showed a lobulated enhancing mass centered in the sella and eroding into the sphenoid sinus. The differential diagnosis includes pituitary macroadenoma versus prostate cancer metastasis. The tumor was resected and the pathological diagnosis was pituitary adenoma.
引用
收藏
页码:E65 / E66
页数:2
相关论文
共 50 条
  • [31] Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT
    Pernthaler, Birgit
    Nazerani Hooshmand, Tina
    Igrec, Jasminka
    Kvaternik, Herbert
    Aigner, Reingard M.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : E231 - E232
  • [32] Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning
    Wang, Tonghe
    Lei, Yang
    Schreibmann, Eduard
    Roper, Justin
    Liu, Tian
    Schuster, David M.
    Jani, Ashesh B.
    Yang, Xiaofeng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] Non-prostate cancer malignancies detected by 18F-Fluciclovine PET/CT
    Barsky, Andrew R.
    Ahn, Grace S.
    Pantel, Austin A.
    Vapiwala, Neha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [34] Papillary Urothelial Carcinoma of Urinary Bladder Identified on 18F-Fluciclovine PET/CT
    Meka, Vamsi Mohan
    Wankhar, Baphiralyne
    Ojili, Vijayanadh
    Batchala, Prem P.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : E438 - E439
  • [35] Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
    Parent, Ephraim E.
    Schuster, David M.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 733 - 739
  • [36] 18F-Fluciclovine Uptake in Thymoma Demonstrated on PET/MRI
    Tsikitas, Lucas
    Karls, Shawn
    Kranz, Anca-Oana
    Friedman, Kent P.
    Mahajan, Sonia
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (03) : e168 - e170
  • [37] Negative 18F-Piflufolastat PET/CT, But Positive 18F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate Cancer
    Ulaner, Gary A.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 968 - 970
  • [38] 18F-fluciclovine PET/MRI in the evaluation of brain glioma
    Karlberg, A.
    Berntsen, E. M.
    Johansen, H.
    Myrthue, M.
    Skjulsvik, A. J.
    Reinertsen, I.
    Esmaeili, M.
    Dai, H. Y.
    Xiao, Y.
    Rivaz, H.
    Borghammer, P.
    Solheim, O.
    Eikenes, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S296 - S297
  • [39] Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study
    Tade, Funmilayo I.
    Cohen, Michael A.
    Styblo, Toncred M.
    Odewole, Oluwaseun A.
    Holbrook, Anna I.
    Newell, Mary S.
    Savir-Baruch, Bital
    Li, Xiaoxian
    Goodman, Mark M.
    Nye, Jonathon A.
    Schuster, David M.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (09) : 1357 - 1363
  • [40] Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18F-Fluciclovine PET/CT
    Wu, Chenxi
    Marcus, Charles
    Baum, Yoram
    Kucuk, Omer
    Schuster, David M.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : 361 - 363